PL1861073T3 - Sposób wytwarzania kompozycji wapnia w złożu fluidalnym pracującym w sposób ciągły - Google Patents

Sposób wytwarzania kompozycji wapnia w złożu fluidalnym pracującym w sposób ciągły

Info

Publication number
PL1861073T3
PL1861073T3 PL06710498T PL06710498T PL1861073T3 PL 1861073 T3 PL1861073 T3 PL 1861073T3 PL 06710498 T PL06710498 T PL 06710498T PL 06710498 T PL06710498 T PL 06710498T PL 1861073 T3 PL1861073 T3 PL 1861073T3
Authority
PL
Poland
Prior art keywords
fluid bed
continuous fluid
production
calcium
calcium compositions
Prior art date
Application number
PL06710498T
Other languages
English (en)
Other versions
PL1861073T5 (pl
Inventor
Jan Yngvar Piene
Kjell Tomas Lunde
Original Assignee
Takeda As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36808838&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1861073(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda As filed Critical Takeda As
Publication of PL1861073T3 publication Critical patent/PL1861073T3/pl
Publication of PL1861073T5 publication Critical patent/PL1861073T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Drying Of Solid Materials (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dental Preparations (AREA)
PL06710498T 2005-03-04 2006-03-06 Sposób wytwarzania kompozycji wapnia w złożu fluidalnym pracującym w sposób ciągły PL1861073T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200500334 2005-03-04
EP06710498.4A EP1861073B8 (en) 2005-03-04 2006-03-06 Process for the production of calcium compositions in a continuous fluid bed
PCT/IB2006/000474 WO2006092727A2 (en) 2005-03-04 2006-03-06 Process for the production of calcium compositions in a continuous fluid bed

Publications (2)

Publication Number Publication Date
PL1861073T3 true PL1861073T3 (pl) 2009-10-30
PL1861073T5 PL1861073T5 (pl) 2012-09-28

Family

ID=36808838

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06710498T PL1861073T5 (pl) 2005-03-04 2006-03-06 Sposób wytwarzania kompozycji wapnia w złożu fluidalnym pracującym w sposób ciągły

Country Status (20)

Country Link
US (1) US20110142928A1 (pl)
EP (1) EP1861073B8 (pl)
JP (2) JP5190273B2 (pl)
CN (1) CN101132774A (pl)
AT (1) ATE430559T1 (pl)
AU (1) AU2006219583B2 (pl)
BR (1) BRPI0607693B8 (pl)
CA (1) CA2599312C (pl)
DE (1) DE602006006658D1 (pl)
DK (1) DK1861073T4 (pl)
EA (1) EA011379B1 (pl)
ES (1) ES2324957T5 (pl)
IL (1) IL185325A (pl)
MX (1) MX2007010519A (pl)
NZ (1) NZ560534A (pl)
PL (1) PL1861073T5 (pl)
PT (1) PT1861073E (pl)
UA (1) UA93502C2 (pl)
WO (1) WO2006092727A2 (pl)
ZA (1) ZA200706879B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8859011B2 (en) 2006-05-12 2014-10-14 Particle Dynamics International, Llc Calcium compositions
JP2010533667A (ja) * 2007-07-19 2010-10-28 ディーエスエム アイピー アセッツ ビー．ブイ． 錠剤化可能な親油性健康成分の配合物
DE102008051572A1 (de) * 2008-09-05 2010-03-11 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Herstellung von Phosphatbindern und auf diese Weise hergestellte Phosphatbinder
US9510617B2 (en) * 2012-04-13 2016-12-06 Frito-Lay North America, Inc. Micropellets of fine particle nutrients and methods of incorporating same into snack food products
US8431155B1 (en) 2012-04-30 2013-04-30 Veroscience Llc Bromocriptine formulations
US9271523B2 (en) 2012-05-23 2016-03-01 Dennis Williams Rotor assembly with one-piece finger member
CN103344093A (zh) * 2013-06-09 2013-10-09 山东奥诺能源科技有限公司 一种立式连续流化床造粒干燥装置及方法
WO2015020191A1 (ja) * 2013-08-09 2015-02-12 日東薬品工業株式会社 カルシウム剤
US10503156B2 (en) * 2015-09-18 2019-12-10 Fisher-Rosemount Systems, Inc. Methods and apparatus to define stages for multi-variate batch control analytics
RU2616399C1 (ru) * 2015-11-17 2017-04-14 Владимир Владимирович Колесник Способ получения биологически активного продукта для адаптивного питания и биологически активный продукт для адаптивного питания
CN107772478A (zh) * 2016-08-24 2018-03-09 南京逐陆医药科技有限公司 一种复合维生素片及其制备方法
CN108261396B (zh) * 2016-12-30 2021-12-24 北京化工大学 一种制粒方法
WO2021043971A1 (en) * 2019-09-06 2021-03-11 Novo Nordisk A/S Method and equipment for fractionation of granules for use in pharmaceutical compositions
CN113679675B (zh) * 2021-09-10 2023-04-07 新疆特丰药业股份有限公司 一种钙颗粒剂及其制备方法和用途
CN114129521A (zh) * 2021-11-05 2022-03-04 昆明源瑞制药有限公司 一种碳酸钙d3颗粒剂及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6197068A (ja) * 1984-10-17 1986-05-15 Okawara Mfg Co Ltd 連続流動層造粒装置における噴霧装置への粉粒体の付着防止方法
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
CA1279574C (en) * 1985-04-17 1991-01-29 Jeffrey L. Finnan Process for lubricating water-soluble vitamin powders
JPS62282629A (ja) * 1986-05-30 1987-12-08 Okawara Mfg Co Ltd 連続式流動層造粒装置
JP2566146B2 (ja) * 1987-08-20 1996-12-25 株式会社大川原製作所 連続式流動層造粒装置
DE4006734C1 (pl) † 1990-03-03 1991-07-25 Benckiser-Knapsack Gmbh, 6802 Ladenburg, De
DK0487774T3 (da) * 1990-11-29 1994-11-21 Wei Ming Pharmaceutical Mfg Co Hjælpestof til direkte tablettering
US5965162A (en) * 1993-09-10 1999-10-12 Fuisz Technologies Ltd. Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom
FR2717387B1 (fr) * 1994-03-17 1996-10-18 Hi Pharmtech Procédé de fabrication de comprimés à croquer à base de troxérutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine d'amoxicilline.
FR2724844B1 (fr) * 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
DE19617487A1 (de) * 1996-05-02 1997-11-06 Merck Patent Gmbh Geschmacksverbesserung von Arzneimittelwirkstoffen
US5939091A (en) * 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
GB0003782D0 (en) † 2000-02-17 2000-04-05 Dumex Ltd As Process
DK1126017T3 (da) * 2000-02-18 2006-02-06 Glatt Ingtech Gmbh Fremgangsmåde til fremstilling af höjeffektive vaskemidler og komponenter i höjeffektive vaskemidler
AR028064A1 (es) * 2000-05-03 2003-04-23 Omnia Fertilizer Ltd Metodo para producir granulos de nitrato de calcio
CA2407329A1 (en) * 2000-05-04 2001-11-08 Dsm N.V. Fluid bed process for the production of enzyme granules
US6499984B1 (en) * 2000-05-22 2002-12-31 Warner-Lambert Company Continuous production of pharmaceutical granulation
CA2440361A1 (en) * 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co. Ltd. Intraorally rapidly disintegrable preparation
WO2005115342A1 (en) * 2004-05-24 2005-12-08 Nycomed Pharma As Particulate comprising a calcium-containing compound and a sugar alcohol

Also Published As

Publication number Publication date
PL1861073T5 (pl) 2012-09-28
DE602006006658D1 (de) 2009-06-18
CN101132774A (zh) 2008-02-27
EP1861073B2 (en) 2012-04-18
EA011379B1 (ru) 2009-02-27
EP1861073B8 (en) 2014-06-04
BRPI0607693A2 (pt) 2010-03-16
BRPI0607693B1 (pt) 2019-04-16
WO2006092727A3 (en) 2006-10-26
ZA200706879B (en) 2009-09-30
ES2324957T3 (es) 2009-08-20
PT1861073E (pt) 2009-06-08
WO2006092727A2 (en) 2006-09-08
EP1861073A2 (en) 2007-12-05
WO2006092727A9 (en) 2006-12-14
AU2006219583A1 (en) 2006-09-08
US20110142928A1 (en) 2011-06-16
JP2013082688A (ja) 2013-05-09
ES2324957T5 (es) 2012-08-21
CA2599312A1 (en) 2006-09-08
EA200701886A1 (ru) 2008-02-28
IL185325A0 (en) 2008-03-20
UA93502C2 (uk) 2011-02-25
IL185325A (en) 2014-04-30
EP1861073B1 (en) 2009-05-06
AU2006219583B2 (en) 2011-11-10
JP5190273B2 (ja) 2013-04-24
NZ560534A (en) 2009-09-25
DK1861073T4 (da) 2012-07-23
JP2008531678A (ja) 2008-08-14
MX2007010519A (es) 2008-01-18
DK1861073T3 (da) 2009-06-15
CA2599312C (en) 2015-12-22
ATE430559T1 (de) 2009-05-15
BRPI0607693B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
IL185325A0 (en) Process for the production of calcium compositions in a continuous fluid bed
SI1896364T1 (sl) Praĺ kasti apneni sestavek, postopek za proizvodnjo in uporaba le-tega
ZA200307450B (en) Process for the production of synthesis gas.
IL177087A0 (en) Controlled-release pharmaceutical composition and method for producing the same
EP1741347A4 (en) FEED ADDITIVE COMPOSITION FOR RETAIL BUYERS, THESE INCLUSIVE FEED AND METHOD FOR PRODUCING A FEED ADDITIVE COMPOSITION FOR REPRODUCTS
IL190654A (en) Methods of Methyl-Sulfonamido-Propanamido, Processes for Preparation and Medicines Containing Them
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
UA98299C2 (ru) Новая лекарственная форма рацекадотрила
EP2070935A4 (en) NOVEL COMPOUND, COMPOSITION COMPRISING SAME, AND PROCESS FOR PRODUCING POLYMERIZABLE AMIDE
PL378127A1 (pl) Sposób wytwarzania cząstek
PL1888514T3 (pl) Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych
GB2406812B (en) Production system for the manufacture of products
TW200517144A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
WO2007003435A3 (de) Verwendung von aktivatoren der löslichen guanylatzyklase zur förderung der wundheilung
AU2003289165A1 (en) Calcium phosphate base particulate compound, process for producing the same and composition comprising the compound
TW200635586A (en) Composition comprising an epothilone and methods for producing a composition comprising an epothilone
AU2003284625A8 (en) Granular composition and process for producing the same
SG153663A1 (en) Process for the production of biodegradable, functionalised polymer particles and use thereof as pharmaceutical supports
EG24987A (en) Process for the production and form preservation of an extruded product made of cementitious material.
GEP20084506B (en) New polysubstituted 1,1-pyridylamino-cyclop¬-ropanamine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200606277B (en) Polysubstituted 1,1-pyridyloxycyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200502316B (en) 4-Oxo-4,6,7,8-tetrahydrop-pyrrolofÄ1,2-aÜpyrazine-6-carbox-amide compounds, a process for their preparation and pharmaceutical compositions containingthem.
UA84701C2 (ru) Замещенные индолы, способ их получения, их использования
GB0329854D0 (en) Process for producing particles for pharmaceutical compositions
HK1081944A1 (en) Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same